These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 2274881)

  • 1. [The possible mechanisms of the refractory nature of chronic circulatory failure].
    Konstantinova IV; Nikolaeva AA
    Ter Arkh; 1990; 62(8):91-3. PubMed ID: 2274881
    [No Abstract]   [Full Text] [Related]  

  • 2. [Monitoring of the serum digoxin concentration in the treatment of refractory heart failure].
    Han G
    Zhonghua Hu Li Za Zhi; 1990 May; 25(5):216-7. PubMed ID: 2357742
    [No Abstract]   [Full Text] [Related]  

  • 3. [Serum digoxin level in right ventricular circulatory insufficiency].
    Halawa B; Mazurek W; Kasprzak-Wójtowicz J
    Wiad Lek; 1981 May; 34(10):805-9. PubMed ID: 7293179
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical application of the measurement of digoxin in blood].
    Cuervo C; Sánchez JL; González Buitrago JM; Martínez I
    Med Clin (Barc); 1983 Apr; 80(12):520-3. PubMed ID: 6865534
    [No Abstract]   [Full Text] [Related]  

  • 5. Low-dose digoxin in heart failure.
    van Veldhuisen DJ; de Boer RA
    Int J Cardiol; 2009 Jul; 136(1):90-1; author reply 91-2. PubMed ID: 18597868
    [No Abstract]   [Full Text] [Related]  

  • 6. [Long-term effects of digoxin and hydralazine in patients with chronic cardiac insufficiency].
    Corbalán R; Arriagada D; Rodríguez JA; Chamorro G; Meleda I; Casanegra P; Valenzuela P
    Rev Med Chil; 1985 Oct; 113(10):947-53. PubMed ID: 3837287
    [No Abstract]   [Full Text] [Related]  

  • 7. [The effectiveness of digoxin and sidnofarm in the initial stages of chronic circulatory failure].
    Bondarenko IP; Tkachev VA
    Vrach Delo; 1989 Oct; (10):73-5. PubMed ID: 2617991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Is there a correlation between the quantitative changes in the electrocardiogram and plasma digoxin concentration?].
    Duraković Z; Culig J; Vrhovac B; Plavsić F
    Srp Arh Celok Lek; 1979 Dec; 107(12):1055-64. PubMed ID: 552166
    [No Abstract]   [Full Text] [Related]  

  • 9. Adjuvant therapy of chronic refractory cardiac failure with oral hydralazine and isosorbide dinitrate.
    Kothiala A; Ramnani K; Patel HR; Mehta NC; Shah CP
    J Assoc Physicians India; 1983 Jun; 31(6):343-6. PubMed ID: 6654793
    [No Abstract]   [Full Text] [Related]  

  • 10. [Complex assessment of treatment effectiveness in cardiopulmonary failure using digoxin controlled by determining its concentration in the blood plasma].
    Sidorova LD; Arkhipova GF; Kudelia LM; Pavlova II; Petrenko VK
    Ter Arkh; 1987; 59(10):47-51. PubMed ID: 3433219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of haemodynamic disturbances on the functions of the liver in chronic circulatory failure.
    Mysik M; Szczeklik J; Pyzik Z; Dubiel JS
    Acta Med Pol; 1980; 21(1):57-67. PubMed ID: 7405627
    [No Abstract]   [Full Text] [Related]  

  • 12. The level of plasma neuroendocrine activity and the concentration of digoxin in the serum of patients with mild chronic heart failure.
    Jablecka A; Chmara E; Korzeniowska K
    Int J Clin Pharmacol Res; 1998; 18(4):171-8. PubMed ID: 10052027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparative assessment of digoxin and captopril in the treatment of chronic congestive circulatory failure, NYHA grade II].
    Lehmann Z; Wierzchowiecki M; Michalski M; Stasiński T; Ozegowski S
    Wiad Lek; 1994 Aug; 47(15-16):574-8. PubMed ID: 7716952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Biochemical evaluation of digoxin dosage in patients with heart failure].
    Jabłecka A
    Wiad Lek; 1994 Aug; 47(15-16):579-82. PubMed ID: 7716953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The use of digoxin, lasix and finoptin in treating circulatory failure in hypertension].
    Orynchak MA
    Ter Arkh; 1989; 61(8):17-21. PubMed ID: 2686070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Relationship between the clinical picture and digoxin level in patients with heart failure in general practice].
    Gundert-Remy U; Karacsonyi P; Remi C; Weber E
    Verh Dtsch Ges Inn Med; 1974; 80():1530-3. PubMed ID: 4454474
    [No Abstract]   [Full Text] [Related]  

  • 17. A comparison between the effects of diltiazem and isosorbide dinitrate on digoxin pharmacodynamics and kinetics in the treatment of patients with chronic ischemic heart failure.
    Mahgoub AA; El-Medany AH; Abdulatif AS
    Saudi Med J; 2002 Jun; 23(6):725-31. PubMed ID: 12070557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The use of the antihypoxants olifen and amtizol for treating patients with chronic stage-IIB circulatory failure].
    Andrianov VP; Boĭtsov SA; Smirnov AV; Shalin IM; Tomchin AB; Zakharova AI; Ivanova VA; Bulyko TM
    Ter Arkh; 1996; 68(5):74-8. PubMed ID: 9082608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Dynamics of respiratory function and and bicycle ergometry in the treatment of patients with chronic circulatory failure].
    Ordian MM; At'kov OIu; Kassirskiĭ SG; Sobol' IuS
    Ter Arkh; 1986; 58(11):48-51. PubMed ID: 3824190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Use of MDRD equation to detect occult renal failure and reduce the risk of digitalis overdose].
    Cepeda Piorno J; Pobes Martínez de Salinas A; González García ME; Fernández Rodríguez E
    Nefrologia; 2009; 29(2):150-5. PubMed ID: 19396321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.